[Controversies in the selection of donors in heart transplants]

U Livi1, G B Luciani, G Thiene

  • 1Istituto di Chirurgia Cardiovascolare, Università di Padova.

Giornale Italiano Di Cardiologia
|December 1, 1992
PubMed

Insights

Extending donor criteria for heart transplantation, including older donors and those with minor issues, can safely expand the donor pool. This approach improves outcomes for heart transplant recipients awaiting organs.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Organ Donor Management

Context:

  • Shortage of ideal donor hearts leads to recipient mortality on waiting lists.
  • Classical donor criteria limit the available organ pool for cardiac transplantation.
  • Need to evaluate extended donor criteria to increase heart availability.

Purpose:

  • To present controversies and clinical results of using donor hearts outside standard criteria.
  • To assess the impact of extended donor criteria on cardiac transplant outcomes.
  • To analyze specific donor factors and their influence on graft performance.

Summary:

  • Extended donor criteria, including age over 40 and certain comorbidities, can be safely used in cardiac transplantation.
  • Donor age >35 years is feasible, with careful assessment of coronary artery disease risk factors.
  • Factors like minor ECG/ECHO changes, localized infection, or trauma may not be absolute contraindications.

Impact:

  • Expanded donor pool without compromising short- and medium-term cardiac transplant outcomes.
  • Highlights the importance of case-by-case evaluation for donor selection.
  • Identifies severe donor dysionemia as a significant risk factor and suggests dopamine infusion levels as predictive.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...